234 related articles for article (PubMed ID: 26895366)
1. Azole Resistance in Dermatophytes: Prevalence and Mechanism of Action.
Ghannoum M
J Am Podiatr Med Assoc; 2016; 106(1):79-86. PubMed ID: 26895366
[TBL] [Abstract][Full Text] [Related]
2. Azole Resistance in Dermatophytes: Prevalence and Mechanism of Action.
Ghannoum M
J Am Podiatr Med Assoc; 2015 Oct; ():. PubMed ID: 26437203
[TBL] [Abstract][Full Text] [Related]
3. [New antifungal agents in the treatment of superficial dermatomycoses].
Degreef H
Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis.
Gupta AK; Talukder M; Shemer A; Galili E
Expert Rev Anti Infect Ther; 2024 Jun; 22(6):399-412. PubMed ID: 38841996
[TBL] [Abstract][Full Text] [Related]
5. Fungal infections of the skin: infection process and antimycotic therapy.
Borgers M; Degreef H; Cauwenbergh G
Curr Drug Targets; 2005 Dec; 6(8):849-62. PubMed ID: 16375669
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates synergistically enhance the antifungal activity of azoles in dermatophytes and other pathogenic molds.
Kane A; Rothwell JG; Guttentag A; Hainsworth S; Carter D
mSphere; 2024 Jun; 9(6):e0024824. PubMed ID: 38837382
[TBL] [Abstract][Full Text] [Related]
7. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
Del Rosso JQ; Kircik LH
J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
[TBL] [Abstract][Full Text] [Related]
8. Antifungal agents: an overview. Part II.
Gupta AK; Sauder DN; Shear NH
J Am Acad Dermatol; 1994 Jun; 30(6):911-33; quiz 934-6. PubMed ID: 7619094
[TBL] [Abstract][Full Text] [Related]
9. Current concepts in systemic and topical therapy for superficial mycoses.
Millikan LE
Clin Dermatol; 2010 Mar; 28(2):212-6. PubMed ID: 20347665
[TBL] [Abstract][Full Text] [Related]
10. Dermatophyte infections.
Hainer BL
Am Fam Physician; 2003 Jan; 67(1):101-8. PubMed ID: 12537173
[TBL] [Abstract][Full Text] [Related]
11. "Azole menace"-An underappreciated trigger perpetuating the epidemic of antifungal therapeutic failure in cutaneous mycoses.
Sonthalia S; Pandey A; Mehndiratta R; Agrawal M; Das S; Shreshtha S
Dermatol Ther; 2021 Jul; 34(4):e14959. PubMed ID: 33857337
[TBL] [Abstract][Full Text] [Related]
12. [The occurrence of dermatophytes in skin mycoses in the area of Conakry in the Republic of Guinea].
Polster M
Dermatol Int; 1967; 6(1):57-8. PubMed ID: 5627182
[No Abstract] [Full Text] [Related]
13. Systematic review of topical treatments for fungal infections of the skin and nails of the feet.
Hart R; Bell-Syer SE; Crawford F; Torgerson DJ; Young P; Russell I
BMJ; 1999 Jul; 319(7202):79-82. PubMed ID: 10398626
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and antifungal susceptibility patterns of dermatophytes isolated from patients with neoplastic diseases: a case control study.
Irimie M; Oanta A; Irimie CA; Minea DI
Acta Dermatovenerol Croat; 2015; 23(2):108-13. PubMed ID: 26228822
[TBL] [Abstract][Full Text] [Related]
15. Azole tolerance test: a bedside observation to enhance physical diagnosis of superficial fungal infection.
Schneiderman H; Kristof L
Conn Med; 2012 Feb; 76(2):124. PubMed ID: 22670369
[No Abstract] [Full Text] [Related]
16. Biochemical basis for the activity and selectivity of oral antifungal drugs.
Vanden Bossche H; Marichal P; Gorrens J; Coene MC
Br J Clin Pract Suppl; 1990 Sep; 71():41-6. PubMed ID: 2091733
[TBL] [Abstract][Full Text] [Related]
17. Conventional and natural compounds for the treatment of dermatophytosis.
Lopes AI; Tavaria FK; Pintado ME
Med Mycol; 2020 Aug; 58(6):707-720. PubMed ID: 31773153
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
[TBL] [Abstract][Full Text] [Related]
19. Overview of topical therapy for common superficial fungal infections and the role of new topical agents.
Brennan B; Leyden JJ
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S3-8. PubMed ID: 9039198
[TBL] [Abstract][Full Text] [Related]
20. Naftifine: A Topical Allylamine for Superficial Dermatophytosis.
Trailokya AA; Shirsat AB; Madhu R; Shah B
J Assoc Physicians India; 2023 May; 71(5):11-12. PubMed ID: 37355825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
